{"brief_title": "Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients", "brief_summary": "The purpose of this study is to evaluate the sirolimus conversion regimen as compared with the calcineurin inhibitor continuation regimen with regards to renal function in stable liver transplant subjects.", "condition": "Liver Transplantation", "intervention_type": "Drug", "intervention_name": "Cyclosporine or Tacrolimus", "arm_group_label": "B", "criteria": "Inclusion Criteria: - Age greater than 13 years (age greater than 18 years as required by some local regulations). - Receiving immunosuppressive therapy with calcineurin inhibitors (CI) +/- corticosteroids +/- antimetabolite. - 6 to 144 months after orthotopic liver transplantation. - Cockcroft-Gault GFR values \u226540 mL/min and \u226490mL/min at screening Exclusion Criteria: - History of nonhepatic transplantation - Evidence of systemic infection (sepsis, bacteremia, pneumonia etc). - Known or suspected malignancy < 5 years before random assignment.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00086346.xml"}